company background image
SIS

Science in Sport AIM:SIS Stock Report

Last Price

UK£0.16

Market Cap

UK£21.4m

7D

-34.7%

1Y

-79.2%

Updated

03 Oct, 2022

Data

Company Financials +
SIS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health3/6
Dividends0/6

SIS Stock Overview

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community.

Science in Sport Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Science in Sport
Historical stock prices
Current Share PriceUK£0.16
52 Week HighUK£0.78
52 Week LowUK£0.16
Beta0.60
1 Month Change-44.83%
3 Month Change-65.22%
1 Year Change-79.22%
3 Year Change-68.63%
5 Year Change-77.31%
Change since IPO-73.55%

Recent News & Updates

Shareholder Returns

SISGB Personal ProductsGB Market
7D-34.7%-5.4%-1.4%
1Y-79.2%-2.5%-14.4%

Return vs Industry: SIS underperformed the UK Personal Products industry which returned -0.9% over the past year.

Return vs Market: SIS underperformed the UK Market which returned -15.2% over the past year.

Price Volatility

Is SIS's price volatile compared to industry and market?
SIS volatility
SIS Average Weekly Movement11.3%
Personal Products Industry Average Movement6.8%
Market Average Movement5.5%
10% most volatile stocks in GB Market10.8%
10% least volatile stocks in GB Market2.9%

Stable Share Price: SIS is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: SIS's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
1992330Steve Moonhttps://www.scienceinsport.com

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; supplements; and vitamins. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains; specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, third-party online sites in the United Kingdom, rest of Europe, the United States, and internationally.

Science in Sport Fundamentals Summary

How do Science in Sport's earnings and revenue compare to its market cap?
SIS fundamental statistics
Market CapUK£21.36m
Earnings (TTM)-UK£12.26m
Revenue (TTM)UK£65.55m

0.3x

P/S Ratio

-1.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SIS income statement (TTM)
RevenueUK£65.55m
Cost of RevenueUK£35.61m
Gross ProfitUK£29.94m
Other ExpensesUK£42.20m
Earnings-UK£12.26m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.092
Gross Margin45.67%
Net Profit Margin-18.70%
Debt/Equity Ratio9.0%

How did SIS perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is SIS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SIS?

Other financial metrics that can be useful for relative valuation.

SIS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.6x
Enterprise Value/EBITDA-6.8x
PEG Ration/a

Price to Sales Ratio vs Peers

How does SIS's PS Ratio compare to its peers?

SIS PS Ratio vs Peers
The above table shows the PS ratio for SIS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average10.3x
CRL Creightons
0.4xn/aUK£24.6m
PXS Provexis
39.5xn/aUK£16.6m
VLG Venture Life Group
0.8x12.7%UK£30.4m
BAR Brand Architekts Group
0.6xn/aUK£8.5m
SIS Science in Sport
0.3x14.5%UK£21.4m

Price-To-Sales vs Peers: SIS is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (10.3x).


Price to Earnings Ratio vs Industry

How does SIS's PE Ratio compare vs other companies in the European Personal Products Industry?

Price-To-Sales vs Industry: SIS is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Personal Products industry average (1.4x)


Price to Sales Ratio vs Fair Ratio

What is SIS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SIS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.8x

Price-To-Sales vs Fair Ratio: SIS is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).


Share Price vs Fair Value

What is the Fair Price of SIS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SIS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SIS's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Science in Sport forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


63.8%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SIS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SIS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SIS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SIS's revenue (14.5% per year) is forecast to grow faster than the UK market (4.4% per year).

High Growth Revenue: SIS's revenue (14.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SIS's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Science in Sport performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-10.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SIS is currently unprofitable.

Growing Profit Margin: SIS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SIS is unprofitable, and losses have increased over the past 5 years at a rate of 10.4% per year.

Accelerating Growth: Unable to compare SIS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SIS is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (27.8%).


Return on Equity

High ROE: SIS has a negative Return on Equity (-32.62%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Science in Sport's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: SIS's short term assets (£20.8M) exceed its short term liabilities (£17.9M).

Long Term Liabilities: SIS's short term assets (£20.8M) exceed its long term liabilities (£15.4M).


Debt to Equity History and Analysis

Debt Level: SIS's net debt to equity ratio (16.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if SIS's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if SIS has enough cash runway based on its current free cash flow.

Forecast Cash Runway: SIS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.5% each year


Discover healthy companies

Dividend

What is Science in Sport current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Science in Sport Dividend Yield vs Market
How does Science in Sport dividend yield compare to the market?
SegmentDividend Yield
Company (Science in Sport)n/a
Market Bottom 25% (GB)2.1%
Market Top 25% (GB)6.0%
Industry Average (Personal Products)2.2%
Analyst forecast in 3 Years (Science in Sport)0%

Notable Dividend: Unable to evaluate SIS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SIS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SIS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SIS's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SIS has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

7.7yrs

Average board tenure


CEO

Steve Moon

9.33yrs

Tenure

UK£1,047,000

Compensation

Mr. Stephen N. Moon, also known as Steve, MBA serves as the Chief Executive Officer of Science in Sport plc. Mr. Moon served as the Chief Executive Officer of Provexis plc since July 24, 2006. He founded a...


CEO Compensation Analysis

Steve Moon's Compensation vs Science in Sport Earnings
How has Steve Moon's remuneration changed compared to Science in Sport's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-UK£12m

Mar 31 2022n/an/a

-UK£10m

Dec 31 2021UK£1mUK£294k

-UK£7m

Sep 30 2021n/an/a

-UK£4m

Jun 30 2021n/an/a

-UK£1m

Mar 31 2021n/an/a

-UK£1m

Dec 31 2020UK£793kUK£274k

-UK£2m

Sep 30 2020n/an/a

-UK£3m

Jun 30 2020n/an/a

-UK£5m

Mar 31 2020n/an/a

-UK£5m

Dec 31 2019UK£706kUK£286k

-UK£6m

Sep 30 2019n/an/a

-UK£6m

Jun 30 2019n/an/a

-UK£6m

Mar 31 2019n/an/a

-UK£6m

Dec 31 2018UK£1mUK£270k

-UK£6m

Sep 30 2018n/an/a

-UK£5m

Jun 30 2018n/an/a

-UK£4m

Mar 31 2018n/an/a

-UK£4m

Dec 31 2017UK£925kUK£230k

-UK£4m

Sep 30 2017n/an/a

-UK£4m

Jun 30 2017n/an/a

-UK£4m

Mar 31 2017n/an/a

-UK£3m

Dec 31 2016UK£956kUK£200k

-UK£3m

Sep 30 2016n/an/a

-UK£2m

Jun 30 2016n/an/a

-UK£1m

Mar 31 2016n/an/a

-UK£1m

Dec 31 2015UK£196kUK£194k

-UK£2m

Compensation vs Market: Steve's total compensation ($USD1.18M) is above average for companies of similar size in the UK market ($USD334.29K).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.


Board Members

Experienced Board: SIS's board of directors are considered experienced (7.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SIS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies106,9420.07%
Individual Insiders1,626,8631.1%
Hedge Funds14,100,7839.8%
Institutions128,117,31189.0%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 102.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.97%
Aviva Investors Global Services Limited
14,649,192£2.3m0%0.01%
10.56%
Otus Capital Management Limited
14,100,783£2.3m0.91%1.46%
8.8%
Pendal Group Limited
11,750,000£1.9m0%0.02%
8.7%
J O Hambro Capital Management Limited
11,615,000£1.9m-4.6%0.01%
8.47%
Lombard Odier Asset Management (Europe) Limited
11,310,049£1.8m417.81%0.03%
8.34%
BennBridge Ltd
11,139,327£1.8m-7.47%0.49%
6.8%
River and Mercantile Asset Management LLP
9,080,570£1.5m-6.03%0.09%
5.41%
Schroder Investment Management Limited
7,217,274£1.2m0%no data
4.9%
Janus Henderson Group plc
6,543,425£1.0m0%no data
4.33%
AXA Investment Managers S.A.
5,775,389£924.1k0%no data
3.97%
Sarasin & Partners LLP
5,303,927£848.6k-1.55%0.01%
3.64%
Baillie Gifford & Co.
4,854,948£776.8k-7.24%no data
2.39%
LGT Capital Partners Ltd.
3,194,044£511.0k0%0.01%
2.25%
Amati Global Investors Ltd.
2,998,778£479.8k0%0.06%
1.8%
Hargreave Hale Limited, Asset Management Arm
2,404,589£384.7k0%0.01%
1.72%
CM-CIC Asset Management Société anonyme
2,300,000£368.0k35.29%0.01%
1.58%
Canaccord Genuity Wealth (International) Limited
2,110,007£337.6k10.38%0.01%
1.43%
UBS Asset Management
1,910,606£305.7k0%no data
1.27%
abrdn plc
1,701,845£272.3k0%no data
1.27%
Roce Capital S.A.S.
1,700,000£272.0k0%0.85%
1.1%
Credit Suisse, Investment Banking and Securities Investments
1,475,000£236.0k-1.67%no data
0.81%
Gresham House Asset Management Limited
1,081,600£173.1k0%0.02%
0.69%
Stephen Moon
924,537£147.9k0%no data
0.61%
A J Bell Holdings Limited, Asset Management Arm
819,620£131.1k-6.7%no data
0.59%
HBOS Investment Fund Managers Limited
792,455£126.8k-2.62%no data

Company Information

Science in Sport plc's employee growth, exchange listings and data sources


Key Information

  • Name: Science in Sport plc
  • Ticker: SIS
  • Exchange: AIM
  • Founded: 1992
  • Industry: Personal Products
  • Sector: Household
  • Implied Market Cap: UK£21.363m
  • Shares outstanding: 133.52m
  • Website: https://www.scienceinsport.com

Number of Employees


Location

  • Science in Sport plc
  • 16-18 Hatton Garden
  • 2nd Floor
  • London
  • Greater London
  • EC1N 8AT
  • United Kingdom


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SISAIM (London Stock Exchange AIM Market)YesNew Ordinary SharesGBGBPAug 2013

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/10/03 00:00
End of Day Share Price2022/10/03 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.